A Network for Advancing Prevention and Treatment of Infections Among Immunocompromised Individuals
There is a dearth of evidence to support the use of many therapies for infectious diseases in immunocompromised individuals, which has substantial impact at the individual and societal level. A multipronged approach to improve integration of, and funding for, rigorous research in this population into the core priorities of the public and private sectors could address important public health gaps by developing evidence-based guidance to protect a vulnerable community.
Authors
- Joshua A. Hill (ORCID: https://orcid.org/0000-0002-7665-7100)
- Natasha Halasa (ORCID: https://orcid.org/0000-0002-6381-1826)
- Michael Boeckh (ORCID: https://orcid.org/0000-0003-1538-7984)
- Steven A. Pergam (ORCID: https://orcid.org/0000-0002-6333-5196)
- Deepali Kumar (ORCID: https://orcid.org/0000-0003-1961-0477)
- Lindsey Robert Baden (ORCID: https://orcid.org/0009-0004-1752-1926)
Institutions
- Brigham and Women's Hospital (US)
- University Health Network (CA)
- University of Washington (US)
- Harvard University Press (US)
- Fred Hutch Cancer Center (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.28383
- Citations
- 1
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Washington Research Foundation